Evaluating quantitative benefit-risk analysis for drug-approval decision making in Europe and the United States
Publication
, Journal Article
Harmon, B; Arrighi, M; Johnson, R; Perez, S
Published in: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
August 1, 2008
Duke Scholars
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
ISSN
1053-8569
Publication Date
August 1, 2008
Volume
17
Start / End Page
S26 / S26
Publisher
JOHN WILEY & SONS LTD
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Harmon, B., Arrighi, M., Johnson, R., & Perez, S. (2008). Evaluating quantitative benefit-risk analysis for drug-approval decision making in Europe and the United States. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 17, S26–S26.
Harmon, Bruno, Michael Arrighi, Reed Johnson, and Susana Perez. “Evaluating quantitative benefit-risk analysis for drug-approval decision making in Europe and the United States.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 17 (August 1, 2008): S26–S26.
Harmon B, Arrighi M, Johnson R, Perez S. Evaluating quantitative benefit-risk analysis for drug-approval decision making in Europe and the United States. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2008 Aug 1;17:S26–S26.
Harmon, Bruno, et al. “Evaluating quantitative benefit-risk analysis for drug-approval decision making in Europe and the United States.” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 17, JOHN WILEY & SONS LTD, Aug. 2008, pp. S26–S26.
Harmon B, Arrighi M, Johnson R, Perez S. Evaluating quantitative benefit-risk analysis for drug-approval decision making in Europe and the United States. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. JOHN WILEY & SONS LTD; 2008 Aug 1;17:S26–S26.
Published In
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
ISSN
1053-8569
Publication Date
August 1, 2008
Volume
17
Start / End Page
S26 / S26
Publisher
JOHN WILEY & SONS LTD
Related Subject Headings
- Pharmacology & Pharmacy
- 4202 Epidemiology
- 3214 Pharmacology and pharmaceutical sciences
- 1117 Public Health and Health Services
- 1115 Pharmacology and Pharmaceutical Sciences